Commentary on TRALI in leukemia

Area of Science:

• Pediatric Hematology
• Transfusion Medicine
• Critical Care

Background:

• Transfusion-Related Acute Lung Injury (TRALI) is a significant cause of transfusion-related morbidity and mortality.
• TRALI is characterized by acute lung injury following blood product transfusion.
• Diagnosis of TRALI in pediatric patients, especially those with comorbidities like leukemia, is challenging due to overlapping symptoms and rarity.

Purpose of the Study:

• To increase awareness of TRALI as a critical differential diagnosis in pediatric patients with acute respiratory distress.
• To highlight the challenges in diagnosing TRALI in immunocompromised and chronically transfused pediatric populations.
• To emphasize the importance of recognizing risk factors for TRALI in hematology/oncology patients.

Main Methods:

• Review of existing literature and case reports on TRALI in pediatric populations.
• Analysis of clinical presentations and diagnostic difficulties in leukemic children.
• Discussion of antibody identification challenges and their intermittent presence.

Main Results:

• Few well-documented cases of pediatric TRALI exist due to underrecognition and diagnostic hurdles.
• Allo-immunized pediatric patients undergoing chronic transfusions are at a higher risk for TRALI.
• Delayed diagnosis can impede timely treatment and preventive strategies.

Conclusions:

• TRALI should be considered in the differential diagnosis of acute respiratory distress in pediatric leukemia patients.
• Enhanced vigilance and diagnostic awareness are necessary for prompt TRALI detection in this vulnerable group.
• Understanding risk factors and facilitating early recognition are key to improving outcomes and implementing preventive measures for TRALI.